Susan G. Komen®, the world’s leading breast cancer organization, issued the following statement on the passage SB 2697, which provides expanded coverage of genetic testing. The bill also ensures that screening recommended based on the results of that testing is covered by a patients’ health insurance. The legislation has been approved by the Illinois legislature […]

Together for a Cure: Fundraising Events Will Further Breast Cancer Research and Support Patients Now Susan G. Komen®, the world’s leading breast cancer organization, is excited to announce 43 locations for the 2024 Susan G. Komen 3-Day, MORE THAN PINK Walk, Race for the Cure and the virtual Walk Where You Are events. From August […]

Susan G. Komen®, the world’s leading breast cancer organization, issued the following statement on the passage of  HB 364, which expands the prohibition of step therapy protocols for metastatic cancer patients to further include associated conditions caused by the side effects of the patient’s cancer treatment. Step therapy, also referred to as “fail first,” requires […]

JEFFERSON CITY, MISSOURI – July 16, 2024 – Susan G. Komen®, the world’s leading breast cancer organization, today issued the following statement on the passage of legislation to expand eligibility for the MO HealthNet Breast and Cervical Cancer Treatment (BCCT) program, ensuring that all eligible individuals have access to vital treatment services, regardless of where […]

New Grants Support Next-Generation Leaders on Their Paths to Independent Research Careers Susan G. Komen®, the world’s leading breast cancer organization, today announced $10.05 million in research grants that aim to improve patient lives through better treatments for metastatic disease and advancements in precision medicine. The 32 grants will further cutting-edge breast cancer research being […]

Ruling Threatens Vital Breast Cancer Screening and Preventive Services for Millions of Americans  Susan G. Komen®, the world’s leading breast cancer organization, today expressed serious concerns about a ruling from the Fifth Circuit Court of Appeals on Braidwood Management, Inc. et al. v. Xavier Becerra et al., a case impacting access to preventive services for […]

Susan G. Komen®, the world’s leading breast cancer organization, today issued the following statement on recent action taken by the Kansas State Employees Health Care Commission (HCC). Earlier this month, the HCC voted unanimously to eliminate the out-of-pocket costs for diagnostic and supplemental imaging for Kansas state employees with an effective date of January 1, […]

Passing Pending Legislation Is Crucial In The Fight Against Breast Cancer  WASHINGTON, DC – Hundreds of advocates are asking members of Congress today to pass pivotal legislation aimed at facilitating affordable access to crucial breast imaging and life-saving treatments for breast cancer. Susan G. Komen®, the world’s leading breast cancer organization, is focused on removing […]

Latest innovations in clinical cancer research discussed at American Society of Clinical Oncology (ASCO) Annual Meeting  Scholars and studies funded by Susan G. Komen, the world’s leading breast cancer organization, showcased cutting-edge breast cancer research aimed at advancing the field at the ASCO Annual Meeting 2024. Organized by the American Society of Clinical Oncology, this […]

Susan G. Komen® Commends Bill Introduction; Urges Quick Passage Susan G. Komen®, the world’s leading breast cancer organization, commends the introduction of legislation to eliminate financial barriers to earlier breast cancer detection by ensuring that everyone has equitable access to diagnostic and supplemental breast imaging as well as needed biopsies. In Ohio, more than 11,500 […]

CONCORD – Susan G. Komen®, the world’s leading breast cancer organization, today issued the following statement on the passage of HB 1296, critical breast imaging legislation in New Hampshire. Diagnostic and supplemental imaging is a critical form of breast cancer screening for some high-risk individuals and an important step in determining the need for a […]

BATON ROUGE – Susan G. Komen®, the world’s leading breast cancer organization, issued the following statement on the passage of SB 338, critical breast imaging legislation in Louisiana. In 2019, Komen worked to pass legislation that provided no-cost coverage for diagnostic breast imaging following an abnormal finding. SB 338 expands upon that coverage to include […]